Physician profile
Mohammad Abbas
NPI 1669826921
$4,937.34
in general payments reported to CMS, 2019-2025
8 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2021: $3,268 · 2022: $500 · 2023: $401 · 2024: $330 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.30 |
| Travel and Lodging | $172.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,760.69 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Pinnacle, INC | $1,206.43 | 2021 | |
| Abbott Laboratories | $584.95 | 2021-2022 | |
| Abbvie INC. | $139.78 | 2021-2024 | Botox |
| Boston Scientific Corporation | $105.22 | 2024-2025 | Watchman Flx, General - Therapies |
| Allergan, INC. | $104.48 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $20.65 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $15.14 | 2023 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.